Frequently Asked Questions
The market is segmented based on Global Deoxyribonucleic Acid (DNA) Vaccines Market, By Type (Human DNA Vaccines, Animal DNA Vaccines), technology (pDNA Vaccines Technology, pDNA Delivery Technology), Application (Human Diseases, Veterinary Diseases Allergies, Others), End-User (Human Health, Animal Health, Research Application), Therapeutic Indications (Vector Borne Disease, Cancer), Type of Vaccines (Genetic Vaccines, Recombinant Protein Vaccines) – Industry Trends and Forecast to 2030.
.
The Global Dna Vaccines Market size was valued at USD 465.60 USD Million in 2022.
The Global Dna Vaccines Market is projected to grow at a CAGR of 7% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffmann, La Roche , Mylan N.V., Teva Pharmaceutical Industries , Sanofi, Pfizer , GSK Plc, Novartis AG, Serum Institute of India Pvt. Ltd, Fotona, GC Biopharma, Zoetis, INOVIO Pharmaceuticals, General Electric, Biomay AG, Valneva SE.
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
